Torrent Pharmaceuticals Limited
Kotak Mutual Fund entered Torrent Pharmaceuticals with 44,98,067 shares, acquiring a 1.18% stake worth ₹214.11 Cr at ₹4763.00 apiece.
A leading Indian pharmaceutical company engaged in research, development, manufacturing and marketing of generic formulations across multiple therapeutic areas. Torrent Pharma operates through a diversified portfolio serving both domestic and international markets, with a focus on affordable healthcare solutions. The company distinguishes itself through its vertically integrated operations, advanced manufacturing facilities, and commitment to delivering quality pharmaceutical products that meet global standards.
Wholly owned subsidiary of Kotak Mahindra Bank, one of India's leading private banks. Manages over Rs 4.5 lakh crore in AUM. MD Nilesh Shah is a fixture in Indian financial media and one of the most quoted fund managers in the country. Known for disciplined quality growth positioning and clear communication of investment rationale to investors.